Results 221 to 230 of about 48,799 (259)

Propranolol and hypertriglyceridemia

Atherosclerosis, 1973
Abstract Eight subjects with elevated fasting plasma triglyceride levels and type IV hypertipoproteinemia, who received a 60 g fat meal before and after 2-week treatment with propranolol, showed an enhanced lipemic response to the meal after the treatment.
H. David Friedberg, H. David Friedberg, Joseph J. Barboriak, Joseph J. Barboriak   +3 more
openaire   +3 more sources

Genomics of hypertriglyceridemia

2020
With regard to heritability of phenotypes, the serum triglyceride level is considered to be highly heritable, with approximately 50% of its variability estimated to derive from parents. Thus, approximately 50% could be modifiable via environmental factors, including lifestyle and medications. Lipoproteins are definitive risk factors for atherosclerotic
Masa-aki Kawashiri, Hayato Tada, Masayuki Takamura   +2 more
openaire   +3 more sources

Hypertriglyceridemia: rationale, design and implementation of the Australian Hypertriglyceridemia Registry

Current Opinion in Endocrinology, Diabetes & Obesity, 2022
Purpose of review Hypertriglyceridemia (HTG) is a risk factor for atherosclerotic cardiovascular disease (ASCVD), aortic stenosis, hepatic steatosis and pancreatitis. We briefly review the aetiology and treatment of HTG and familial chylomicronemia syndrome (FCS), as well as the implementation of a clinical quality registry for
Pang, J., Li, Stephen C. (R20659), Chan, D. C., Sullivan, D. R., Woodward, A.-M., Watts, G. F.   +5 more
openaire   +3 more sources

Pathophysiology of hypertriglyceridemia

Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2012
The importance of triglycerides as risk factor for CVD is currently under debate. The international guidelines do not include TG into their risk calculator despite the recent observations that plasma TG is an independent risk factor for CVD. The understanding of the pathophysiology of triglycerides opens up avenues for development of new drug targets ...
M. Nieuwdorp, E.S. Stroes, Geesje M. Dallinga-Thie, H. C. Hassing, H.L. Mooij, R.P. Surendran   +5 more
openaire   +3 more sources

Treatment of hypertriglyceridemia

Current Diabetes Reports, 2006
Hypertriglyceridemia is a disorder commonly encountered in clinical practice. Treatment of this condition aims to prevent the major complications of hypertriglyceridemia, which differ depending on whether triglyceride elevations are moderate or severe.
Warren H. Capell, Robert H. Eckel
openaire   +3 more sources

Management of hypertriglyceridemia

BMJ, 2020
AbstractHypertriglyceridemia is one of the most common lipid abnormalities encountered in clinical practice. Many monogenic disorders causing severe hypertriglyceridemia have been identified, but in most patients triglyceride elevations result from a combination of multiple genetic variations with small effects and environmental factors.
openaire   +3 more sources

Targeting FoxO1 for Hypertriglyceridemia

Current Drug Targets, 2011
Hypertriglyceridemia is characterized by increased production and decreased clearance of triglyceride-rich lipoproteins including very low-density lipoprotein (VLDL) and chylomicron. Due to its proatherogenic profile, hypertriglyceridemia contributes to the development of atherosclerosis and coronary artery disease.
Steven Ringquist, Ting Zhang, Dae Hyun Kim, H. Henry Dong   +3 more
openaire   +3 more sources

Ascorbic Acid and Hypertriglyceridemia

Annals of Internal Medicine, 1980
Excerpt To the editor: Although increased blood lipid levels have been associated with lowered intracellular and extracellular ascorbic acid levels (1, 2), few or no data exist on treatment of hype...
Louis H. Diamond, Kenneth L. Geoly
openaire   +3 more sources

Hypertriglyceridemia in Youth

The Journal of Pediatrics, 2022
Don P, Wilson, Lauren, Williams, Rae-Ellen W, Kavey   +2 more
openaire   +2 more sources

Tamoxifen and hypertriglyceridemia

The Netherlands Journal of Medicine, 1999
Abstract A patient developed severe hypertriglyceridemia while on treatment with Tamoxifen after a mastectomy and with a statin for a lipid disorder. The mechanism of this side effect and the therapeutic effect of a fibrate are discussed. (See Editorial p. 47)
openaire   +2 more sources